OpenAI offers academic labs free GPT-Rosalind access
OpenAI's new Rosalind Academic Plan gives eligible U.S. university labs up to 30 free seats for a year, with access to its life-sciences model GPT-Rosalind only after trusted-access vetting.
OpenAI announced the Rosalind Academic Plan, a sponsored access program meant to bring GPT-Rosalind, its dedicated life-sciences model, to more academic labs. The program widens access to an existing model rather than adding new capabilities.
Eligible labs can get up to 30 Business Standard seats at $0 per user per month for up to 12 months. The seats include access to all of OpenAI's commercially available frontier models, subject to plan usage limits. GPT-Rosalind itself is available only after trusted-access approval. It is paired with Rosalind Workbench, which OpenAI describes as handling specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance and other scientific work. API access is not included for now. OpenAI says research data shared through the plan is not used for model training by default.
The plan is open only to academic labs at U.S. universities. PIs and lab leads at institutions without an OpenAI Enterprise agreement apply on behalf of their labs. Labs at universities that already have an agreement must apply through their institution's Enterprise process.
Vetting is the core of the program. Before activating access, OpenAI says it verifies the institution and the lead's identity. It also reviews the lead's professional background and appointment, assesses the lab's research and intended use, and requires a designated institutional safety contact. After approval, monitoring and enforcement continue, and safety checks for registered high-sensitivity work take the approved research context into account. Verified lab leads manage member permissions and are responsible for their lab's use.
OpenAI said labs are already using the model for work ranging from protein design to neurodegeneration research. It did not name the labs or give results. It also did not say how many labs it expects to admit.